Industries > Pharma > Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

PUBLISHED: 17 December 2018
PAGES: 232
PRODUCT CODE: PHA0345
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0345 Categories: , Tags: , , , ,

The global rheumatoid arthritis drugs market will reach $47bn in 2024. In 2018, the Biologics submarket held 87% of the Global Rheumatoid Arthritis drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 232-page report you will receive 234 charts– all unavailable elsewhere.

The 232-page report provides clear detailed insight into the rheumatoid arthritis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Rheumatoid Arthritis Market from 2019-2029

• Forecast of the Global Rheumatoid Arthritis market by Submarket:
• Biologics
• Non-Biologics: NSAIDs, sDMARDs and Others

• Forecast of the leading drugs in the Global Rheumatoid Arthritis market:
• Humira
• Enbrel
• Remicade
• Rituxan/MabThera
• Simponi/Simponi Aria
• Orencia
• Actemra/Roactemra
• Cimzia
• Celebrex
• Xeljanz
• Arcoxia
• Others

Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• Europe: Germany, France, United Kingdom, Italy, Spain, Russia and rest of Europe
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA

Each regional market is further segmented into Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

• Our study discusses the selected leading companies that are the major players in the rheumatoid arthritis market:
• AbbVie
• Amgen
• AstraZeneca
• BMS
• Eli Lilly
• Johnson & Johnson
• Merck & Co
• Novartis
• Pfizer
• Roche
• Sanofi
• UCB

• Our study discusses selected compounds under development for rheumatoid arthritis.

• This study provides a SWOT and STEP analysis of the rheumatoid arthritis drugs market.

Visiongain’s study is intended for anyone requiring commercial analyses for the rheumatoid arthritis market. You find data, trends and predictions.

Buy our report today Global Rheumatoid Arthritis Drugs Market Analysis : Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

      Latest Pharma news

      Infertility Drugs & Devices Market

      The global Infertility Drugs & Devices market is projected to grow at a CAGR of 6.2% by 2034

      27 June 2024

      READ

      Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market

      The global Highly Potent Active Pharmaceutical Ingredients Market is Projected to Grow at a CAGR of 9.6% by 2034

      27 June 2024

      READ

      Cell & Gene Therapy Cold Chain Logistics Market

      The global Cell and Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15.5% by 2034

      19 June 2024

      READ

      Cancer Immunotherapy Market

      The global Cancer Immunotherapy market is projected to grow at a CAGR of 12.6% by 2034

      11 June 2024

      READ